Comparison of the expression data between patient groups defined by clinical and histomorphological parameters (Table 1) revealed a statistical significant difference only for pT categories, indicating a decrease in HTRA1 mRNA levels with increasing tumor stage (p = 0.025). The gene discussed is HTRA1; the disease is neoplasm.